Related Experiment Video
Updated: Sep 29, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Impact of renal failure on the risk of myocardial infarction and death
Srinivasan Beddhu1, Kristina Allen-Brady, Alfred K Cheung
1Renal Section, Salt Lake VA Healthcare System, Salt Lake City, Utah, USA. Srinivasan.beddhu@hsc.utah.edu
Insights
Renal failure significantly increases the risk of myocardial infarction and death, even at moderate stages. This risk is independent of other known cardiovascular disease factors and treatments.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- High cardiovascular morbidity and mortality are observed in patients with renal failure.
- It remains unclear if pre-existing cardiovascular disease or the uremic state itself drives this increased risk.
Purpose of the Study:
- To determine if renal failure independently elevates the risk of myocardial infarction and death.
Main Methods:
- The Intermountain Heart Study included 8600 patients undergoing coronary angiography.
- Glomerular filtration rate (GFR) was calculated using the Modification of Diet in Renal Disease formula.
- Cox regression models analyzed the association between GFR and outcomes like myocardial infarction and death.
Main Results:
- Patients in the lowest GFR quartile (mean GFR 41 mL/min) faced significantly higher risks.
- Adjusted analyses showed increased risk for myocardial infarction (RR 1.51) and death (RR 2.60) in the lowest GFR quartile.
- These associations persisted even after accounting for coronary disease severity and treatment.
Conclusions:
- Moderate renal failure independently elevates the risk of myocardial infarction and death.
- This increased risk is evident irrespective of clinical variables, baseline coronary disease, or therapy.
- Findings highlight the critical role of kidney function in cardiovascular outcomes.
Background:
It is unclear whether pre-existing cardiovascular disease or predisposition of the uremic state leads to the high cardiovascular morbidity and mortality associated with renal failure. We examined whether renal failure independently increases the risk of myocardial infarction and death.
Methods:
A total of 8600 patients with variable glomerular filtration rate (GFR) at the time of coronary angiography participated in the Intermountain Heart Study. Coronary disease was defined as >or=70% stenosis. Modification of Diet in Renal Disease formula was used to calculate glomerular filtration rate (GFR). Cox regression models were used to compare outcomes.
Results:
The mean GFR was 71 +/- 24 mL/min. There were 1320 (15%) deaths, 657 (9%) myocardial infarctions and 1776 (21%) death or myocardial infarctions over 3.2 +/- 1.9 years. Compared to the highest GFR quartile, the lowest GFR quartile (mean GFR 41 +/- 14 mL/min) was associated with higher risk for myocardial infarction (RR 1.43, 95% CI 1.15 to 1.78), death (RR 2.77, 95% CI 2.32 to 3.30) and death/myocardial infarction (RR 2.13, 95% CI 1.85 to 2.45) in multivariable models adjusted for age, sex, hypertension, hyperlipidemia, smoking, family history of coronary disease and diabetes. Even after further adjustment for coronary angiographic data and the choice of initial therapy, lowest GFR quartile was associated with increased risk of myocardial infarction (RR 1.51, 95% CI 1.21 to 1.88), death (RR 2.60, 95% CI 2.18 to 3.10) and death/myocardial infarction (RR 2.08, 95% CI 1.80 to 2.39).
Conclusions:
Even moderate renal failure increases the risk of myocardial infarction and death independent of clinical variables, baseline angiographic evidence of coronary disease and therapy.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: Diuretics
Acute Kidney Injury I: Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Myocarditis I: Introduction
